相关实验视频

Updated: May 17, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

对T细胞的单细胞元分析揭示了对检查点免疫治疗反应的克隆动态

Ofir Shorer¹, Asaf Pinhasi¹, Keren Yizhak²

¹Department of Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 3525422, Israel.

|April 5, 2025

概括

扩展的CD8+T细胞克隆揭示了与患者对免疫检查点抑制剂的反应相关的独特的转录状态. 这些发现提供了对抗瘤免疫机制和患者结果的见解.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
基因组学就是基因组学.

背景情况:

T细胞克隆对抗瘤免疫至关重要,但它们在免疫检查点抑制剂 (ICI) 反应中的作用尚不清楚.
描述T细胞克隆及其与ICI治疗后临床结果的关联对于改善治疗策略至关重要.

研究的目的:

研究T细胞克隆特征在预测对免疫检查点抑制剂反应中的作用.
确定与ICI治疗的癌症患者的不同临床结果相关的T细胞特征.

主要方法:

配对单细胞RNA测序和T细胞受体测序在6种癌症类型的460个样本中的767,606个T细胞上进行.
分析包括扩展和持久T细胞克隆的鉴定,基因表达概况和伪时间状态分析.
对瘤中的T细胞克隆和来自响应者与非响应者的血液样本进行比较分析.

主要成果:

根据扩展的CD8+T细胞克隆,确定了显著的响应特征,区分了响应者与非响应者.
与不响应者相比,响应者的持久克隆表现出转录性变化,表明增强了复原能力.
新的克隆显示了与临床结果相关的伪时间状态变化,共享的瘤血克隆在非响应者中更为丰富.

结论:

T细胞克隆转录状态的差异与患者对免疫检查点抑制剂的反应有关.
扩展和持久的T细胞克隆为预测ICI疗效提供了有价值的生物标志物.
了解T细胞克隆动态,可以了解抗瘤免疫机制和潜在的治疗点.

关键词:

在T细胞的克隆性.免疫检查点抑制剂免疫检查点抑制剂这是一个元分析.在配对的scRNA/TCR-seqq中.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

相关概念视频

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.